Question

A 57-year-old with untreated HTN presents with average BP 152/96 mm Hg (Stage 2). 10-year ASCVD risk 13%. No target organ damage. Management per U.S. guideline?

Accepted Answer

Start two first-line agents of different classes

Answer

Lifestyle only; recheck in 6 months

Answer

Start single agent and recheck in 3 months

Answer

Start beta-blocker monotherapy

Answer

No therapy until ASCVD risk >=20%

Practice question

A 57-year-old with untreated HTN presents with average BP 152/96 mm Hg (Stage 2). 10-year ASCVD risk 13%. No target organ damage. Management per U.S. guideline?